Finance

Lists
Why is MIRA down ३.०६%?
Dive Deeper
MIRA:NASDAQ
Mira Pharmaceuticals Inc
US$ ०.८४
-३.०६%
(-०.०२७) 1D
US$ ०.८२
-२.९०% (-०.०२५)
After hours
Closed: सेप्टेम्बर ३०, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRA...
Open
US$ ०.८६
High
US$ ०.८७
Low
US$ ०.८२
Mkt. cap
३.५६ करोड
Avg. vol.
११.२४ लाख
Volume
०.००
52-wk high
US$ २.४५
52-wk low
US$ ०.६०
EPS
-US$ १.३८
Beta
१.५२
Shares outstanding
४.२० करोड
No. of employees
३
Open
US$ ०.८६
High
US$ ०.८७
Low
US$ ०.८२
Mkt. cap
३.५६ करोड
Avg. vol.
११.२४ लाख
Volume
०.००
52-wk high
US$ २.४५
52-wk low
US$ ०.६०
EPS
-US$ १.३८
Beta
१.५२
Shares outstanding
४.२० करोड
No. of employees
३
News stories
From web sources and news partners
The Dark Side Of The Boom
The Dark Side Of The Boom
·
१ घण्टा पहिले
BTIG’s Krinsky Says the Million-Dollar Question Is Turning Into a Major Frustration
Simply Wall Street
Simply Wall Street
·
२७ मिनेट पहिले
Learn Why The Bull Case For Amplitude (AMPL) Could Change Following Earnings Beat
marketscreener.com
marketscreener.com
·
१ घण्टा पहिले
S&P 500 index retreated after the Stockholm exchange closed on Wednesday
WSJ
WSJ
·
७ घण्टा पहिले
A Tech-Fueled Stock Market Powers Through, but Limps Into the Fourth Quarter
About Mira Pharmaceuticals Inc
CEO-
Employees३
Founded२०२०
Headquartersमायामी, फ्लोरिडा, संयुक्त राज्य अमेरिका
Sector-
Websitemirapharmaceuticals.com
Analyst ratings
Based on 1 analyst giving stock ratings to MIRA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MIRA in the last 3 months
Highest
Current US$ ०.८४
US$ ३.५० (+३१४.३०%)
Average
US$ ३.५० (+३१४.३०%)
Lowest
US$ ३.५० (+३१४.३०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Initiated
US$ ३.५०
+३१४.३%
09/17/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$ ८.००
+८४७%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४.१३ लाख
४.९७ लाख
५.२५ लाख
७.०६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९.०४ लाख
५३.२८ लाख
५.७९ लाख
४.५० लाख
Operating expense
१३.१७ लाख
५८.२५ लाख
११.०३ लाख
११.५६ लाख
Total operating expenses
१३.१७ लाख
५८.२५ लाख
११.०३ लाख
११.५६ लाख
Operating income
-१३.१७ लाख
-५८.२५ लाख
-११.०३ लाख
-११.५६ लाख
Other non operating income
-१२.४४ हजार
-३९६.००
-
-
EBT including unusual items
-११.३८ लाख
-५९.८३ लाख
-११.५० लाख
-१२.०९ लाख
EBT excluding unusual items
-१३.१४ लाख
-५७.७२ लाख
-११.५० लाख
-१२.०९ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-११.३८ लाख
-५९.८३ लाख
-११.५० लाख
-१२.०९ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.०७
-
-
-
Interest and investment income
१५.७० हजार
५३.१७ हजार
४४.९१ हजार
३५.१३ हजार
Interest expense
-
-
-
-
Net interest expenses
१५.७० हजार
५३.१७ हजार
४४.९१ हजार
३५.१३ हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू